Immuneering Corporation, a leader in drug discovery fueled by bioinformatics, announced the appointment of Biren Amin ’00, as chief financial officer. Amin joins Immuneering from Jefferies Financial Group Inc. after having spent nearly two decades on Wall Street building an impeccable track record as an equity research analyst covering small and mid-cap biotechnology companies focused on oncology, central nervous system disorders, ophthalmology and rare diseases.
